Germany
,02.May, 2022
Exyte GmbH changes its board structure in line with accelerated growth path, the “Pathway to Ten”
In order to align the leadership structure of Exyte with its strategic growth plan 'Pathway to Ten' (Exyte’s plan to reach annual sales of €10 bn by 2027), the Executive Board together with the Supervisory Board of Exyte have decided to strengthen the three strategic units of Exyte, Advanced Technology Facilities (ATF), Biopharma and Life Sciences (BLS), and Data Centers (DTC) by extending the Executive Board of Exyte with respective Board representations of these segments. As a consequence, the role of the Chief Operating Officer will be abolished while three new Board positions are created. The future Board of Exyte will comprise five members.
Loading….